Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sotio a.s.
DescriptionActive cellular immunotherapy for ovarian cancer that uses a patient's dendritic cells to induce an immune reaction against presented tumor antigens
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationOvarian cancer
Indication DetailsTreat epithelial ovarian cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today